My Quote Request
No products added yet
6505-01-505-8466
20 Products
NDC00075-0622-80
ENOXAPARIN INJECTION
NSN, MFG P/N
6505015058466
NSN
6505-01-505-8466
NDC00075-0622-80
ENOXAPARIN INJECTION
NSN, MFG P/N
6505015058466
NSN
6505-01-505-8466
MFG
SANOFI-AVENTIS U.S. INC
Description
ADMINISTRATION: SUBCUTANEOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201204
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ENOXAPARIN INJECTION 80MG IN 0.8ML WATER FOR INJECTION 10S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: 80MG OF ENOXAPARIN SODIUM IN 0.8ML OR 10MG ENOXAPARIN SODIUM PER 0.1ML IN WATER FOR INJECTION; GRADUATED PREFILLED SYRINGE AFFIXED WITH 27 GAUGE 1/2 IN. NEEDLE; STORE AT CONTROLLED ROOM TEMP 15-25 DEG C
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
6515NCM021825
CELECOXIB CAPSULES
NSN, MFG P/N
6505015055932
NSN
6505-01-505-5932
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280804
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CELECOXIB CAPS/100MG 100S
SPECIAL FEATURES: 100MG. CELECOXIB CAPSULES; A NONSTEROIDAL ANTI-INFLAMMATORY DRUG THAT EXHIBITS ANTI-INFLAMMATORY, ANALGESIC AND ANTIPYRETIC ACTIVITIES; STORE AT CONTROLLED ROOM TEMPERATURE; 100 PER BOTTLE
Related Searches:
NDC00025-1520-31
CELECOXIB CAPSULES
NSN, MFG P/N
6505015055932
NSN
6505-01-505-5932
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 280804
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CELECOXIB CAPS/100MG 100S
SPECIAL FEATURES: 100MG. CELECOXIB CAPSULES; A NONSTEROIDAL ANTI-INFLAMMATORY DRUG THAT EXHIBITS ANTI-INFLAMMATORY, ANALGESIC AND ANTIPYRETIC ACTIVITIES; STORE AT CONTROLLED ROOM TEMPERATURE; 100 PER BOTTLE
Related Searches:
03-0011
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505015056009
NSN
6505-01-505-6009
03-0011
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505015056009
NSN
6505-01-505-6009
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 144.000 MILLIGRAMS SALICYLIC ACID PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 842800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALICYLIC ACID COLLODION MODIFIED 15ML EA
III PROTECTIVE STORAGE FEATURE: CORROSIVE AND POISONOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH APPLICATOR
SPECIAL FEATURES: 17% W/W IN A FLEXIBLE, COLLODION OR COLLODION-LIKE VEHICLE; SUPPLIED IN A 15ML BOTTLE WITH APPLICATOR
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC45802-0236-63
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505015056009
NSN
6505-01-505-6009
NDC45802-0236-63
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505015056009
NSN
6505-01-505-6009
MFG
CLAY-PARK LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 144.000 MILLIGRAMS SALICYLIC ACID PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 842800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALICYLIC ACID COLLODION MODIFIED 15ML EA
III PROTECTIVE STORAGE FEATURE: CORROSIVE AND POISONOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH APPLICATOR
SPECIAL FEATURES: 17% W/W IN A FLEXIBLE, COLLODION OR COLLODION-LIKE VEHICLE; SUPPLIED IN A 15ML BOTTLE WITH APPLICATOR
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
WART REMOVER LIQUID
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505015056009
NSN
6505-01-505-6009
WART REMOVER LIQUID
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505015056009
NSN
6505-01-505-6009
MFG
CLAY-PARK LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 144.000 MILLIGRAMS SALICYLIC ACID PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 842800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALICYLIC ACID COLLODION MODIFIED 15ML EA
III PROTECTIVE STORAGE FEATURE: CORROSIVE AND POISONOUS
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH APPLICATOR
SPECIAL FEATURES: 17% W/W IN A FLEXIBLE, COLLODION OR COLLODION-LIKE VEHICLE; SUPPLIED IN A 15ML BOTTLE WITH APPLICATOR
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
03-0355
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015056025
NSN
6505-01-505-6025
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM INJECTION USP 4MG/ML 1ML CARTRIDGE UNIT 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE UNIT
SPECIAL FEATURES: CARPUJECT W/LUERLOCK, NEEDLELESS, SLIMPAK
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-1539-31
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015056025
NSN
6505-01-505-6025
NDC00074-1539-31
LORAZEPAM INJECTION,USP
NSN, MFG P/N
6505015056025
NSN
6505-01-505-6025
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 282408
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LORAZEPAM INJECTION USP 4MG/ML 1ML CARTRIDGE UNIT 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: CARTRIDGE UNIT
SPECIAL FEATURES: CARPUJECT W/LUERLOCK, NEEDLELESS, SLIMPAK
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
03-0032
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
03-0032
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 262.000MG BISMUTH SUBSALICYLATE PER 15ML
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 560800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBSALICYLATE PEPTO-BISMOL 8OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LIQUID; TO TREAT INDIGESTION, NAUSEA, DIARRHEA AND STOMACH CRAMPS; STORE AT ROOM TEMPERATURE; AVAILABLE IN CASES OF 12 8OZ BOTTLES
Related Searches:
NDC00182-1811-44
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
NDC00182-1811-44
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 262.000MG BISMUTH SUBSALICYLATE PER 15ML
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 560800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBSALICYLATE PEPTO-BISMOL 8OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LIQUID; TO TREAT INDIGESTION, NAUSEA, DIARRHEA AND STOMACH CRAMPS; STORE AT ROOM TEMPERATURE; AVAILABLE IN CASES OF 12 8OZ BOTTLES
Related Searches:
NDC00904-1313-09
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
NDC00904-1313-09
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 262.000MG BISMUTH SUBSALICYLATE PER 15ML
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 560800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBSALICYLATE PEPTO-BISMOL 8OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LIQUID; TO TREAT INDIGESTION, NAUSEA, DIARRHEA AND STOMACH CRAMPS; STORE AT ROOM TEMPERATURE; AVAILABLE IN CASES OF 12 8OZ BOTTLES
Related Searches:
PINK BISMUTH
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
PINK BISMUTH
BISMUTH SUBSALICYLATE SUSPENSION
NSN, MFG P/N
6505015056483
NSN
6505-01-505-6483
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 262.000MG BISMUTH SUBSALICYLATE PER 15ML
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 560800
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISMUTH SUBSALICYLATE PEPTO-BISMOL 8OZ BT
PRIMARY CONTAINER CONTENT QUANTITY: 240.000 MILLILITERS OR 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LIQUID; TO TREAT INDIGESTION, NAUSEA, DIARRHEA AND STOMACH CRAMPS; STORE AT ROOM TEMPERATURE; AVAILABLE IN CASES OF 12 8OZ BOTTLES
Related Searches:
03-0056
BUPROPION HYDROCHLORIDE TABETS
NSN, MFG P/N
6505015056640
NSN
6505-01-505-6640
03-0056
BUPROPION HYDROCHLORIDE TABETS
NSN, MFG P/N
6505015056640
NSN
6505-01-505-6640
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281604
COATING FEATURE: FILM, NONENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS
SUPPLEMENTARY FEATURES: ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00173-0556-01
BUPROPION HYDROCHLORIDE TABETS
NSN, MFG P/N
6505015056640
NSN
6505-01-505-6640
NDC00173-0556-01
BUPROPION HYDROCHLORIDE TABETS
NSN, MFG P/N
6505015056640
NSN
6505-01-505-6640
MFG
GLAXOSMITHKLINE CONSUMER HEALTHCARE LP DBA GLAXOSMITHKLINE CONSUMER HEALTHCARE DIV GLAXOSMITHKLINE CONSUMER HEALTHCARE LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281604
COATING FEATURE: FILM, NONENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS
SUPPLEMENTARY FEATURES: ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
ZYBAN
BUPROPION HYDROCHLORIDE TABETS
NSN, MFG P/N
6505015056640
NSN
6505-01-505-6640
MFG
GLAXOSMITHKLINE CONSUMER HEALTHCARE LP DBA GLAXOSMITHKLINE CONSUMER HEALTHCARE DIV GLAXOSMITHKLINE CONSUMER HEALTHCARE LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS BUPROPION HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 281604
COATING FEATURE: FILM, NONENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPROPION HYDROCHLORIDE ZYBAN ADVANTAGE PACK BT 150MG 60 TABS INCLUDES PATIENT BOOKLET
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: TO HELP WITH A PLAN TO QUIT SMOKING; STORE AT CONTROLLED ROOM TEMP.; DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINERS; SUSTAINED-RELEASED TABLETS; BOX CONTAINS 1 BOTTLE WITH PATIENT BOOKLET/INSTRUCTIONS
SUPPLEMENTARY FEATURES: ADVANTAGE PACK, INCLUDES BT. AND PATIENT BOOKLET
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
03-0061
FEXOFENADINE HYDROC
NSN, MFG P/N
6505015057721
NSN
6505-01-505-7721
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 180MG; 100S BT
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FEXODFENADINE HYDROCHLORIDE TABLETS ALLEGRA 180MG 100 BT
Related Searches:
ALLEGRA TABLETS
FEXOFENADINE HYDROC
NSN, MFG P/N
6505015057721
NSN
6505-01-505-7721
MFG
SANOFI-AVENTIS U.S. INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 180MG; 100S BT
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FEXODFENADINE HYDROCHLORIDE TABLETS ALLEGRA 180MG 100 BT
Related Searches:
NDC00088-1109-47
FEXOFENADINE HYDROC
NSN, MFG P/N
6505015057721
NSN
6505-01-505-7721
MFG
SANOFI-AVENTIS U.S. INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 180MG; 100S BT
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FEXODFENADINE HYDROCHLORIDE TABLETS ALLEGRA 180MG 100 BT
Related Searches:
NDC00378-0755-01
FEXOFENADINE HYDROC
NSN, MFG P/N
6505015057721
NSN
6505-01-505-7721
MFG
MYLAN PHARMACEUTICALS INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 180MG; 100S BT
III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 040000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FEXODFENADINE HYDROCHLORIDE TABLETS ALLEGRA 180MG 100 BT
Related Searches:
LOVENOX
ENOXAPARIN INJECTION
NSN, MFG P/N
6505015058466
NSN
6505-01-505-8466
MFG
SANOFI-AVENTIS U.S. INC
Description
ADMINISTRATION: SUBCUTANEOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 201204
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ENOXAPARIN INJECTION 80MG IN 0.8ML WATER FOR INJECTION 10S
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: 80MG OF ENOXAPARIN SODIUM IN 0.8ML OR 10MG ENOXAPARIN SODIUM PER 0.1ML IN WATER FOR INJECTION; GRADUATED PREFILLED SYRINGE AFFIXED WITH 27 GAUGE 1/2 IN. NEEDLE; STORE AT CONTROLLED ROOM TEMP 15-25 DEG C
TOTAL PRIMARY CONTAINER QUANTITY: 10
